It has been shown that CXCL8 is upregulated in TAMs and promotes ESCC invasion and metastasis via CXCR1/CXCR2 receptors to activate AKT and ERK1/2 signaling pathways (52). This evidence concerns the gene MAPK3 and esophageal squamous cell carcinoma.